PodParley PodParley

What's Next for Moderna?

The biotech company is best known for its COVID-19 vaccine, but Moderna CEO Stéphane Bancel says there are myriad uses for its mRNA platform.

Episode 12 of the Leadership Next podcast, hosted by Fortune, titled "What's Next for Moderna?" was published on April 25, 2023 and runs 29 minutes.

April 25, 2023 ·29m · Leadership Next

0:00 / 0:00

In 2019, Moderna reported revenues of sixty million dollars. By 2022 it was number 195 on the Fortune 500 with over $18 billion in revenue. This meteoric rise was due to Moderna's development of one of the major COVID-19 vaccines. Now, thankfully, the height of the pandemic has passed and the need for these vaccines is far less urgent. There is something to be said about your marquee product being less useful because people are healthier, but where does Moderna go from here? And how will its CEO Stéphane Bancel help it get there? In this episode of Leadership Next, Bancel talks with hosts Alan Murray and Michal Lev-Ram about the other uses for Moderna's proprietary mRNA platform - including potential vaccines for cancer and H.I.V. Bancel also discusses Moderna's controversial plan to start charging as much as $130 a dose for the COVID-19 vaccine once the U.S. ends the pandemic public health emergency on May 11th. Explore more of Fortune! Use the promo code LN25 to get 25% off an annual subscription at fortune.com/subscribe. Leadership Next is powered by Deloitte.

In 2019, Moderna reported revenues of sixty million dollars. By 2022 it was number 195 on the Fortune 500 with over $18 billion in revenue. This meteoric rise was due to Moderna's development of one of the major COVID-19 vaccines. Now, thankfully, the height of the pandemic has passed and the need for these vaccines is far less urgent. There is something to be said about your marquee product being less useful because people are healthier, but where does Moderna go from here? And how will its CEO Stéphane Bancel help it get there? In this episode of Leadership Next, Bancel talks with hosts Alan Murray and Michal Lev-Ram about the other uses for Moderna's proprietary mRNA platform - including potential vaccines for cancer and H.I.V. Bancel also discusses Moderna's controversial plan to start charging as much as $130 a dose for the COVID-19 vaccine once the U.S. ends the pandemic public health emergency on May 11th. Explore more of Fortune! Use the promo code LN25 to get 25% off an annual subscription at fortune.com/subscribe. Leadership Next is powered by Deloitte.
The Richard Blackaby Leadership Podcast Dr. Richard Blackaby The Richard Blackaby Leadership Podcast helps people take their leadership to the next level. Christian Rocketeers: Rocket Your Nonprofit Leadership Today! Christian Rocketeers Empowering your nonprofit leadership Where Christian nonprofits explore the latest trends and strategies in nonprofit leadership!Practical tips to elevate your nonprofit leadership game QUICKLY. Valuable knowledge, inspiration & empowerment for greater impact!Don't miss out on the opportunity to take your nonprofit leadership to the next level!! Lean Smarts Podcast: Lean Manufacturing | Leadership Lean Smarts Podcast: Lean Manufacturing | Leadership Daniel Crawford, founder of Lean Smarts, shares about all things related to lean manufacturing at work, home, and in life. If you want to understand lean, become a lean thinker, and take your leadership to the next level, this is the show for you! The Courageous Leaders Podcast Joanna Howes The Courageous Leaders Podcast aims to inspire leaders to step into their courageous zone, be the leader they know they can be and discover the mindset skills and behaviours to take their leadership to the next level. So listen in, get inspired on how you can grow your leadership impact. Leave a legacy you can be proud of, and build an environment for future leaders to thrive. Who is Joanna Howes?Joanna Howes is an award-winning international coach, behavioural expert, specialising in leadership and performance coaching and No 1 best selling international co-author. Her focus is to help individuals and teams activate their full potential, so they can step into their courageous zone to maximise their influence, build their resilience and take the action needed to become high performers and future-ready leaders.Joanna is a unique phenomenon within her industry, with over 20 years’ experience working internationally with some of the world's
URL copied to clipboard!